Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature
Fraietta, Joseph A JA; Nobles, Christopher L CL; Sammons, Morgan A MA; Lundh, Stefan S; Carty, Shannon A SA; Reich, Tyler J TJ; Cogdill, Alexandria P AP; Morrissette, Jennifer J D JJD; DeNizio, Jamie E JE; Reddy, Shantan S; Hwang, Young Y; Gohil, Mercy M; Kulikovskaya, Irina I; Nazimuddin, Farzana F; Gupta, Minnal M; Chen, Fang F; Everett, John K JK; Alexander, Katherine A KA; Lin-Shiao, Enrique E; Gee, Marvin H MH; Liu, Xiaojun X; Young, Regina M RM; Ambrose, David D; Wang, Yan Y; Xu, Jun J; Jordan, Martha S MS; Marcucci, Katherine T KT; Levine, Bruce L BL; Garcia, K Christopher KC; Zhao, Yangbing Y; Kalos, Michael M; Porter, David L DL; Kohli, Rahul M RM; Lacey, Simon F SF; Berger, Shelley L SL; Bushman, Frederic D FD; June, Carl H CH; Melenhorst, J Joseph JJ